You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 18, 2024

ADENOSINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Adenosine patents expire, and when can generic versions of Adenosine launch?

Adenosine is a drug marketed by Am Regent, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Mylan Labs Ltd, Rising, Teva Pharms Usa, Wockhardt, Avet Lifesciences, Eugia Pharma, Hospira, Meitheal, and Mylan Asi. and is included in twenty-one NDAs.

The generic ingredient in ADENOSINE is adenosine. There are twenty-six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the adenosine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Adenosine

A generic version of ADENOSINE was approved as adenosine by HIKMA on June 16th, 2004.

  Try a Trial

Drug patent expirations by year for ADENOSINE
Drug Prices for ADENOSINE

See drug prices for ADENOSINE

Recent Clinical Trials for ADENOSINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Artios Pharma LtdPhase 1/Phase 2
Arab Contractors Medical CentrePhase 4
Cairo UniversityPhase 2

See all ADENOSINE clinical trials

Pharmacology for ADENOSINE
Medical Subject Heading (MeSH) Categories for ADENOSINE
Anatomical Therapeutic Chemical (ATC) Classes for ADENOSINE
Paragraph IV (Patent) Challenges for ADENOSINE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ADENOSCAN Injection adenosine 3 mg/mL, 20 mL and 30 mL vials 020059 1 2005-04-18

US Patents and Regulatory Information for ADENOSINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rising ADENOSINE adenosine SOLUTION;INTRAVENOUS 090450-002 Oct 2, 2014 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Am Regent ADENOSINE adenosine INJECTABLE;INJECTION 090010-001 Apr 28, 2009 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Eugia Pharma ADENOSINE adenosine SOLUTION;INTRAVENOUS 205331-002 Nov 2, 2017 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Meitheal ADENOSINE adenosine SOLUTION;INTRAVENOUS 077425-002 Aug 29, 2013 AP RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hikma ADENOSINE adenosine INJECTABLE;INJECTION 076500-001 Jun 16, 2004 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Gland Pharma Ltd ADENOSINE adenosine INJECTABLE;INJECTION 077283-001 Jun 14, 2007 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.